Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
32%
OVERLAP
BY WEIGHT
20
# OF OVERLAPPING
HOLDINGS
PJP
32
HOLDINGS
71%
ALSO IN XPH
XPH
60
HOLDINGS
34%
ALSO IN PJP
SECTOR DRIFT (PJP minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
LIQUIDIA TECHNOLOGIES, INC. | 3.4% | 1.8% | 1.8% |
|
LIGAND PHARMACEUTICALS-CL B | 3.3% | 1.8% | 1.8% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | 3.6% | 1.8% | 1.8% |
|
CORCEPT THERAPEUTICS INC | 3.8% | 1.7% | 1.7% |
|
VIATRIS, INC. | 2.7% | 1.6% | 1.6% |
PJP Overweight Relative to XPH
|
ABBOTT LABORATORIES | 5.2% |
|
ABBVIE INC | 5.1% |
|
AMGEN INC | 5.1% |
|
GILEAD SCIENCES INC | 4.7% |
|
ELI LILLY & CO | 3.7% |
|
TRAVERE THERAPEUTICS, INC. | 3.5% |
|
PFIZER INC | 3.5% |
|
JOHNSON & JOHNSON | 3.4% |
|
MERCK & CO. INC. | 3.2% |
|
BIOGEN IDEC INC | 2.9% |
PJP Underweight Relative to XPH
|
CRINETICS PHARMACEUTICALS INC | -3.7% |
|
MBX BIOSCIENCES INC | -3.1% |
|
DEFINIUM THERAPEUTICS INC | -2.9% |
|
ENLIVEN THERAPEUTICS, INC. | -2.2% |
|
ALUMIS INC | -2.1% |
|
TREVI THERAPEUTICS, INC. | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.0% |
|
HARROW INC | -2.0% |
|
NUVATION BIO INC CLASS A | -1.9% |
|
EDGEWISE THERAPEUTICS, INC. | -1.8% |